Xu M, Xin W, Xu J, Wang A, Ma S, Dai D
Nat Commun. 2025; 16(1):2551.
PMID: 40089457
DOI: 10.1038/s41467-025-57890-8.
Park H, Yeo S, Lee T, Han Y, Ryu C, Huh C
Front Microbiol. 2025; 16:1538620.
PMID: 40051478
PMC: 11884817.
DOI: 10.3389/fmicb.2025.1538620.
Akiyama S, Hayashi R, Takasago T, Kusunoki K, Ikeuchi H, Takenaka K
J Gastroenterol. 2025; .
PMID: 40050487
DOI: 10.1007/s00535-025-02231-1.
St-Pierre J, Choi D, Fear E, Choi N, Mathew A, Cohen R
Dig Dis Sci. 2025; .
PMID: 40048134
DOI: 10.1007/s10620-025-08950-y.
Torres J, DHaens G, Regueiro M, Santana G, Panes J, Vermeire S
Therap Adv Gastroenterol. 2025; 18:17562848251318849.
PMID: 40028509
PMC: 11869240.
DOI: 10.1177/17562848251318849.
Efficacy and safety of two-step acupuncture therapy for symptom relief in adults with mild to moderate ulcerative colitis: rationale and design of the TSA-UC randomised controlled trial.
Chen H, Fang J, Liu S, Gao S, Shi H, Ma J
BMJ Open. 2025; 15(2):e094301.
PMID: 40021194
PMC: 11873345.
DOI: 10.1136/bmjopen-2024-094301.
Patient and Health Care Professional Perspectives on the Burden and Daily Life Impact of Ulcerative Colitis and Crohn's Disease: Results from the Japanese CONFIDE Study.
Hibi T, Kobayashi T, Tanaka M, Osaga S, Potts Bleakman A, Hunter Gibble T
Adv Ther. 2025; .
PMID: 40016440
DOI: 10.1007/s12325-024-03078-3.
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Hasskamp J, Meinhardt C, Patton P, Timmer A
Cochrane Database Syst Rev. 2025; 2:CD000478.
PMID: 40013523
PMC: 11866470.
DOI: 10.1002/14651858.CD000478.pub5.
A practical approach to positioning therapies in ulcerative colitis.
Yanofsky R, Rubin D
J Can Assoc Gastroenterol. 2025; 8(Suppl 2):S6-S14.
PMID: 39990515
PMC: 11842905.
DOI: 10.1093/jcag/gwae058.
Development of a Claims-Based Computable Phenotype for Ulcerative Colitis Flares.
Copeland D, Marwaha J, Wong D, Yuan W, Fakler M, Kennedy C
medRxiv. 2025; .
PMID: 39974105
PMC: 11838973.
DOI: 10.1101/2025.01.26.25321138.
Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real-World Data.
Sealey D, Ho K, Zhou Z, Clark M, Feagan B, Panaccione R
Can J Gastroenterol Hepatol. 2025; 2025:5713315.
PMID: 39959029
PMC: 11825194.
DOI: 10.1155/cjgh/5713315.
Network pharmacology and experimental verification in vivo reveal the mechanism of Zhushao Granules against ulcerative colitis.
Gong B, Zhang C, Hu S, Zhang X, Zou H, Li J
Biol Proced Online. 2025; 27(1):7.
PMID: 39953430
PMC: 11827476.
DOI: 10.1186/s12575-025-00268-3.
Molecular Mechanisms and Clinical Aspects of Colitis-Associated Cancer in Ulcerative Colitis.
Yamamoto-Furusho J, Gutierrez-Herrera F
Cells. 2025; 14(3).
PMID: 39936954
PMC: 11817687.
DOI: 10.3390/cells14030162.
Exploring Dual-Targeted Therapy in the Management of Moderate to Severe Inflammatory Bowel Disease: A Retrospective Study.
Bhaskar S, Makovich Z, Mhaskar R, Coughlin E, Seminerio-Diehl J
Crohns Colitis 360. 2025; 7(1):otae057.
PMID: 39877297
PMC: 11772558.
DOI: 10.1093/crocol/otae057.
Live Typhoid and Yellow Fever Vaccines Administered to a Patient With Ulcerative Colitis on Vedolizumab.
Hegde Y, Hayney M, Caldera F
ACG Case Rep J. 2025; 11(10):e01507.
PMID: 39866528
PMC: 11759320.
DOI: 10.14309/crj.0000000000001507.
The Importance of Post-Inflammatory Polyps (PIPs) in Colorectal Cancer Surveillance in Inflammatory Bowel Diseases.
Candel I, Wetwittayakhlang P, Bessissow T, Lakatos P
J Clin Med. 2025; 14(2).
PMID: 39860339
PMC: 11765530.
DOI: 10.3390/jcm14020333.
Huanglian Ejiao Decoction Alleviates Ulcerative Colitis in Mice Through Regulating the Gut Microbiota and Inhibiting the Ratio of Th1 and Th2 Cells.
Tang J, Hu Y, Fang J, Zhu W, Xu W, Yu D
Drug Des Devel Ther. 2025; 19():303-324.
PMID: 39845151
PMC: 11750730.
DOI: 10.2147/DDDT.S468608.
Dysplasia and Colorectal Cancer Surveillance in Ulcerative Colitis Patients in Latin America: Real-World Data.
Parra-Izquierdo V, Otero-Regino W, Juliao-Banos F, Frias-Ordonez J, Ibanez-Pinilla E, Gil-Parada F
Crohns Colitis 360. 2025; 7(1):otae081.
PMID: 39834355
PMC: 11744193.
DOI: 10.1093/crocol/otae081.
Correlation and diagnostic significance of CD4 T cell subsets and NLRP3 inflammasome in ulcerative colitis: the role of the NLRP3/T-bet/GATA3 axis.
Hu Y, Tang J, Yu D, Su S, Fang J, Xia L
BMC Gastroenterol. 2025; 25(1):23.
PMID: 39833691
PMC: 11748810.
DOI: 10.1186/s12876-025-03603-w.
Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis.
Zhang W, Zhao S, Li J, Sun Y, Wang X
Front Pharmacol. 2025; 15():1481678.
PMID: 39830339
PMC: 11739108.
DOI: 10.3389/fphar.2024.1481678.